Although effective therapies are crucial, adverse events, financial burden, and other factors make a "taper-to-target" approach appealing to both pediatric patients and their caregivers.
Lana Dykes
Advertisement
Articles by Lana Dykes
Long-term corticosteroids during pregnancy is associated with maternal and fetal adverse outcomes which may influence the insulin resistance later in life.
The approvals were based on results from the JUNIPERA trial, which showed secukinumab reduced the risk of flare and disease activity when compared with placebo over 2 years in pediatric patients with ERA and JPsA.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Neurodevelopmental disorder risks not increased by prenatal acetaminophen use
2
Tapinarof cream, 1% (VTAMA) shows early improvements in pediatric atopic dermatitis
3
Study: Child maltreatment rates declined overall, but disparities persisted across sex and race
4
FDA updates Elevidys labeling with boxed warning and revised indication following reports of fatal liver injury
5
